Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid
Unique ID
C469683
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C469683
Entry Term(s)
TAK 427
TAK-427
TAK427
Registry Numbers
0
Heading Mapped to
*Imidazoles
*Pyridazines
Frequency
4
Note
TAK-427 is the dihydrate; an antiallergic agent and NSAID; structure in first source
Source
J Pharmacol Exp Ther 2002 Dec;303(3):1283-90
Date of Entry
2002/12/20
Revision Date
2003/02/24
2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid Preferred
TAK 427 Narrower
page delivered in 0.006s